Nkarta Therapeutics
Updated March 2021.
88%
Employees say this is a great place to work
Company Overview
About The Company
Nkarta is a clinical-stage biotechnology company developing allogeneic, off the shelf natural killer (NK) cell therapies for cancer. Founded in 2015 at the birthplace of biotechnology in South San Francisco, CA, Nkarta became a public company (Nasdaq TX) in 2020.
COMPANY SIZE
99 U.S.-based Employees
(Small)
Industry
Biotechnology & Pharmaceuticals
HQ Location
South San Francisco, CA, US
Interested in a career at Nkarta Therapeutics, or just want to know more?
To discover what sets Nkarta Therapeutics apart and explore relevant career opportunities, take a look at their website.
Employee Demographics
Tenure
Company Culture at Nkarta Therapeutics
The employee experience below at Nkarta Therapeutics, compared to a typical company.
Learn More88% of employees at Nkarta Therapeutics say it is a great place to work compared to 57% of employees at a typical U.S.-based company.
97%
I believe management would lay people off only as a last resort.
96%
People here are given a lot of responsibility.
96%
Management is honest and ethical in its business practices.
95%
Our executives fully embody the best characteristics of our company.
94%
Management is competent at running the business.
Why Work at Nkarta Therapeutics?
See what employees say about what makes Nkarta Therapeutics a great workplace. These words are drawn from employee comments on the Trust Index™ survey.
CONNECT